-
公开(公告)号:US08822444B2
公开(公告)日:2014-09-02
申请号:US13548298
申请日:2012-07-13
申请人: Omar D. Lopez , Qi Chen , Makonen Belema , Lawrence G. Hamann
发明人: Omar D. Lopez , Qi Chen , Makonen Belema , Lawrence G. Hamann
CPC分类号: C07D403/14 , C07D413/14
摘要: This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
摘要翻译: 本公开涉及如说明书中定义的式(I)新化合物和包含这些新化合物的组合物。 这些化合物是有用的抗病毒剂,特别是抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白的功能。 因此,本公开还涉及通过使用这些新化合物或包含这些新化合物的组合物治疗HCV相关疾病或病症的方法。
-
公开(公告)号:US08809548B2
公开(公告)日:2014-08-19
申请号:US12701919
申请日:2010-02-08
申请人: Jeffrey Lee Romine , Denis R. St. Laurent , Makonen Belema , Lawrence B. Snyder , Lawrence G. Hamann , John F. Kadow , Jayne Kapur , Andrew C. Good , Omar D. Lopez , Rico Lavoie , John A. Bender
发明人: Jeffrey Lee Romine , Denis R. St. Laurent , Makonen Belema , Lawrence B. Snyder , Lawrence G. Hamann , John F. Kadow , Jayne Kapur , Andrew C. Good , Omar D. Lopez , Rico Lavoie , John A. Bender
IPC分类号: A61K31/422 , A61K31/4184 , C07D403/14 , C07D413/14
CPC分类号: C07D403/14 , A61K31/4184 , A61K31/422 , A61K31/454 , A61K31/4725 , A61K31/7056 , A61K38/2013 , A61K38/204 , A61K38/208 , A61K38/21 , A61K38/212 , A61K45/06 , C07D405/14 , C07D413/14
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
公开(公告)号:US08574563B2
公开(公告)日:2013-11-05
申请号:US13609957
申请日:2012-09-11
申请人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
发明人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
IPC分类号: C07D403/14 , C07D417/14 , C07D405/14 , C07D401/14 , A61K31/506 , A61K31/427 , A61K38/21 , A61K31/7056 , A61K31/7105 , A61K31/4745 , A61K38/20 , A61P31/16
CPC分类号: A61K31/506 , A61K31/13 , A61K31/4178 , A61K31/427 , A61K31/4745 , A61K31/7056 , A61K31/7105 , A61K38/2013 , A61K38/204 , A61K38/208 , A61K38/21 , A61K38/212 , C07D401/14 , C07D403/14 , C07D405/14 , C07D417/14
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
公开(公告)号:US08303944B2
公开(公告)日:2012-11-06
申请号:US12030232
申请日:2008-02-13
申请人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
发明人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
IPC分类号: C07D403/14 , A61K31/4178 , A61K31/506 , A61K31/16 , A61K31/7088 , A61K38/20 , A61K38/21 , A61K38/43 , A61K38/48 , A61P31/12
CPC分类号: A61K31/506 , A61K31/13 , A61K31/4178 , A61K31/427 , A61K31/4745 , A61K31/7056 , A61K31/7105 , A61K38/2013 , A61K38/204 , A61K38/208 , A61K38/21 , A61K38/212 , C07D401/14 , C07D403/14 , C07D405/14 , C07D417/14
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
65.Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof 有权
标题翻译: 二肽基肽酶IV抑制剂的生产方法和化合物及其中间体公开(公告)号:US08278462B2
公开(公告)日:2012-10-02
申请号:US12712958
申请日:2010-02-25
申请人: Truc Chi Vu , David B. Brzozowski , Rita Fox , Jollie Duaine Godfrey, Jr. , Ronald L. Hanson , Sergei V. Kolotuchin , John A. Mazzullo , Ramesh N. Patel , Jianji Wang , Kwok Wong , Jurong Yu , Jason J. Zhu , David R. Magnin , David J. Augeri , Lawrence G. Hamann
发明人: Truc Chi Vu , David B. Brzozowski , Rita Fox , Jollie Duaine Godfrey, Jr. , Ronald L. Hanson , Sergei V. Kolotuchin , John A. Mazzullo , Ramesh N. Patel , Jianji Wang , Kwok Wong , Jurong Yu , Jason J. Zhu , David R. Magnin , David J. Augeri , Lawrence G. Hamann
IPC分类号: C07D209/52
CPC分类号: C07C69/757 , C07C62/06 , C07C69/635 , C07C69/675 , C07C229/28 , C07C271/22 , C07C2603/74 , C07D207/22 , C07D209/52
摘要: Methods and compounds for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV are provided.
摘要翻译: 提供了用于制备二肽基肽酶IV的环丙基稠合吡咯烷基抑制剂的方法和化合物。
-
公开(公告)号:US08242124B2
公开(公告)日:2012-08-14
申请号:US12490727
申请日:2009-06-24
申请人: Alicia Regueiro-Ren , Jacob Swidorski , Zheng Liu , Tao Wang , Zhongxing Zhang , Lawrence G. Hamann , Nicholas A. Meanwell , David J. Carini , Wenying Li
发明人: Alicia Regueiro-Ren , Jacob Swidorski , Zheng Liu , Tao Wang , Zhongxing Zhang , Lawrence G. Hamann , Nicholas A. Meanwell , David J. Carini , Wenying Li
IPC分类号: A61K31/519 , A61K31/44 , C07D471/04
CPC分类号: C07D471/04 , C07D519/00
摘要: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketopiperidine derivatives that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.
摘要翻译: 阐述了具有药物和生物影响特性的化合物,其药物组合物和使用方法。 特别提供具有独特抗病毒活性的二酮哌啶衍生物。 这些化合物可用于治疗艾滋病毒和艾滋病。
-
公开(公告)号:US08147818B2
公开(公告)日:2012-04-03
申请号:US12358587
申请日:2009-01-23
申请人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
发明人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
IPC分类号: A61K38/20 , A61K31/4184 , A61K31/55 , A61K38/05 , A61K38/21 , A61K31/708 , C07D403/14 , C07D487/04
CPC分类号: C07D403/14 , C07D405/14 , C07D487/04 , C07D491/044 , C07D491/052
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
68.DIKETO FUSED AZOLOPIPERIDINES AND AZOLOPIPERAZINES AS ANTI-HIV AGENTS 有权
标题翻译: 作为抗HIV药物的DIKETO FASED AZOLOPIPERIDINES和AZOLOPIPERAZINES公开(公告)号:US20110212971A1
公开(公告)日:2011-09-01
申请号:US13101591
申请日:2011-05-05
申请人: Tao Wang , Yasutsugu Ueda , Lawrence G. Hamann , Zhongxing Zhang , Zhiwei Yin , Alicia Regueiro-Ren , David J. Carini , Jacob Swidorski , Zheng Liu , Nicolas A. Meanwell , John F. Kadow , Barry L. Johnson
发明人: Tao Wang , Yasutsugu Ueda , Lawrence G. Hamann , Zhongxing Zhang , Zhiwei Yin , Alicia Regueiro-Ren , David J. Carini , Jacob Swidorski , Zheng Liu , Nicolas A. Meanwell , John F. Kadow , Barry L. Johnson
IPC分类号: A61K31/4985 , C07D471/04 , A61K31/506 , A61K31/437 , A61K31/497 , C07D241/04 , A61K31/495 , C07D487/04 , A61P31/18
CPC分类号: C07D487/04 , C07D471/04 , C07D519/00
摘要: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketo fused azolopiperidine and azolopiperazine derivatives that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.
摘要翻译: 阐述了具有药物和生物影响特性的化合物,其药物组合物和使用方法。 特别地,提供具有独特抗病毒活性的二酮稠合偶氮哌啶和偶氮哌嗪衍生物。 这些化合物可用于治疗艾滋病毒和艾滋病。
-
69.Diketo-Piperazine and Piperidine derivatives as antiviral agents 有权
标题翻译: Diketo-Piperazine和哌啶衍生物作为抗病毒剂公开(公告)号:US07807676B2
公开(公告)日:2010-10-05
申请号:US11877001
申请日:2007-10-23
申请人: Tao Wang , John F. Kadow , Zhongxing Zhang , Zhiwei Yin , Nicholas A. Meanwell , Alicia Regueiro-Ren , Jacob Swidorski , Ying Han , David J. Carini , Lawrence G. Hamann
发明人: Tao Wang , John F. Kadow , Zhongxing Zhang , Zhiwei Yin , Nicholas A. Meanwell , Alicia Regueiro-Ren , Jacob Swidorski , Ying Han , David J. Carini , Lawrence G. Hamann
IPC分类号: A61K31/437 , A61K31/501 , A61K31/506 , C07D471/04
CPC分类号: C07D471/04 , C07D403/12 , C07D417/14
摘要: This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with diketo piperazine and piperadine derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.
摘要翻译: 本公开提供具有药物和生物影响性质的化合物,其药物组合物和使用方法。 特别地,本公开涉及具有独特抗病毒活性的二酮哌嗪和哌嗪衍生物。 更具体地,本公开涉及可用于治疗HIV和AIDS的化合物。
-
公开(公告)号:US07745636B2
公开(公告)日:2010-06-29
申请号:US12029680
申请日:2008-02-12
申请人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
发明人: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
IPC分类号: C07D233/02 , A01N43/50
CPC分类号: C07D403/14
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
-
-
-
-
-
-
-
-